Brainsway Ltd (BWAY) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, Brainsway Ltd (BWAY) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.39 Million ≈ $3.72K USD) by net assets (ILA70.06 Million ≈ $187.84K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Brainsway Ltd (BWAY) total market value for the company's overall valuation and market capitalisation.

Brainsway Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Brainsway Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Brainsway Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brainsway Ltd ranked by their cash flow conversion efficiency. Explore Brainsway Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hangzhou Zhongya Machinery Co Ltd
SHE:300512
0.026x
Tangel Publishing
SHE:300148
-0.009x
Posiflex Technology Inc
TW:8114
-0.061x
PureTech Health PLC
NASDAQ:PRTC
-0.126x
Guangdong Huiyun Titanium Industry
SHE:300891
-0.003x
Israel Land Development Company Co Ltd
TA:ILDC
0.013x
Norma Group AG NA O.N.
XETRA:NOEJ
0.035x
Yunnan Yuntou Ecology and Environment Technology Co Ltd
SHE:002200
-0.032x

Annual Cash Flow Conversion Efficiency for Brainsway Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Brainsway Ltd from 2012 to 2024. View BWAY live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA62.31 Million
≈ $167.06K
ILA10.30 Million
≈ $27.61K
0.165x +435.19%
2023-12-31 ILA41.58 Million
≈ $111.48K
ILA1.28 Million
≈ $3.44K
0.031x +114.36%
2022-12-31 ILA45.40 Million
≈ $121.71K
ILA-9.76 Million
≈ $-26.16K
-0.215x -1494.00%
2021-12-31 ILA57.32 Million
≈ $153.68K
ILA884.00K
≈ $2.37K
0.015x +121.08%
2020-12-31 ILA19.63 Million
≈ $52.64K
ILA-1.44 Million
≈ $-3.85K
-0.073x +75.55%
2019-12-31 ILA24.22 Million
≈ $64.93K
ILA-7.24 Million
≈ $-19.42K
-0.299x +44.89%
2018-12-31 ILA6.95 Million
≈ $18.64K
ILA-3.77 Million
≈ $-10.12K
-0.543x -99.13%
2017-12-31 ILA12.72 Million
≈ $34.10K
ILA-3.47 Million
≈ $-9.29K
-0.273x -16.72%
2016-12-31 ILA10.29 Million
≈ $27.58K
ILA-2.40 Million
≈ $-6.44K
-0.233x +33.85%
2015-12-31 ILA12.89 Million
≈ $34.57K
ILA-4.55 Million
≈ $-12.20K
-0.353x -44.97%
2014-12-31 ILA15.58 Million
≈ $41.76K
ILA-3.79 Million
≈ $-10.17K
-0.244x -50.97%
2013-12-31 ILA14.65 Million
≈ $39.28K
ILA-2.36 Million
≈ $-6.34K
-0.161x +74.07%
2012-12-31 ILA9.01 Million
≈ $24.15K
ILA-5.60 Million
≈ $-15.02K
-0.622x --

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$422.69 Million
ILA157.66 Billion ILA
Market Cap Rank
#13157 Global
#139 in Israel
Share Price
ILA4020.00
Change (1 day)
-2.19%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more